City

Chicago (1)

Dallas (1)

Hong Kong (1)

Houston (1)

Los Angeles (1)

New Haven (1)

Philadelphia (1)

San Francisco (1)

Seattle (1)

Condition

Novel Coronavirus Infection (2)

Cardiovascular Diseases (1)

Covid19 (1)

ME/CFS (1)

Neurocognitive Disorders (1)

SARS COV2 (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Phase

phase 2 (1)

Sponsor

Rush University Medical Center (1)

The University of Hong Kong (1)

Collaborator

Hospital Authority, Hong Kong (1)

The University of Texas Health Science Center, Houston (1)

Thomas Jefferson University (1)

University of California, Los Angeles (1)

University of California, San Francisco (1)

University of Texas Southwestern Medical Center (1)

University of Washington (1)

Yale University (1)

Intervention

interferon beta-1b (1)

lopinavir/ritonavir (1)

ribavirin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

novel coronavirus infection

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Covid19, ME/CFS, SARS COV2 Trial in United States

Active, not recruiting

Covid19
+5 more

Los Angeles, California
+7 more

Sep 1, 2022

Novel Coronavirus Infection Trial in Hong Kong (Lopinavir/ritonavir, Ribavirin, Interferon Beta-1B)

Completed

Novel Coronavirus Infection

Lopinavir/ritonavir
+2 more

Hong Kong, Hong Kong

University of Hong Kong, Queen Mary Hospital

Apr 13, 2020